Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Data processing circuit with arbitration between a plurality of queues
Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes
Apparatus and method for foreground detection
Surface emitting laser device, surface emitting laser array, optical scanning device, and image forming apparatus
Managing and collaborating with digital content
Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations
Cryptography on a simplified elliptical curve
  Randomly Featured Patents
Container crusher and method of crushing
RFID drawer integration with cash handling devices and point of sale devices
Staged oil filter incorporating additive-releasing particles
Receiver with filters offset correction
Anticonvulsive compositions and method of treating convulsive disorders
Graphic data processing system
Flexible delivery system for a rotatable probe
Roughness diagnostic tool
Passive seismic data acquisition and processing using multi-level sensor arrays
Microscope viewing device